These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 26463822)
21. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Vogt J; Perozzo R; Pautsch A; Prota A; Schelling P; Pilger B; Folkers G; Scapozza L; Schulz GE Proteins; 2000 Dec; 41(4):545-53. PubMed ID: 11056041 [TBL] [Abstract][Full Text] [Related]
22. Effect of acyclovir on thermal stress-induced herpesvirus reactivation. Gebhardt BM; Kaufman HE; Hill JM Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960 [TBL] [Abstract][Full Text] [Related]
23. Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System. Li L; Li Z; Wang E; Yang R; Xiao Y; Han H; Lang F; Li X; Xia Y; Gao F; Li Q; Fraser NW; Zhou J J Virol; 2016 Jan; 90(2):790-804. PubMed ID: 26512084 [TBL] [Abstract][Full Text] [Related]
24. Human thymidine kinase can functionally replace herpes simplex virus type 1 thymidine kinase for viral replication in mouse sensory ganglia and reactivation from latency upon explant. Chen SH; Cook WJ; Grove KL; Coen DM J Virol; 1998 Aug; 72(8):6710-5. PubMed ID: 9658118 [TBL] [Abstract][Full Text] [Related]
25. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. LeBlanc RA; Pesnicak L; Godleski M; Straus SE J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344 [TBL] [Abstract][Full Text] [Related]
26. 5-(Trifluoromethyl)-beta-l-2'-deoxyuridine, the L-enantiomer of trifluorothymidine: stereospecific synthesis and antiherpetic evaluations. Salvetti R; Marchand A; Pregnolato M; Verri A; Spadari S; Focher F; Briant M; Sommadossi JP; Mathé C; Gosselin G Bioorg Med Chem; 2001 Jul; 9(7):1731-8. PubMed ID: 11425574 [TBL] [Abstract][Full Text] [Related]
27. A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia. Sawtell NM; Bernstein DI; Stanberry LR J Infect Dis; 1999 Sep; 180(3):821-3. PubMed ID: 10438371 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses. Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818 [TBL] [Abstract][Full Text] [Related]
29. Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo. Thompson RL; Sawtell NM J Virol; 2006 Nov; 80(22):10919-30. PubMed ID: 16943285 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of herpes simplex virus reactivation by dipyridamole in a mouse model. Hay KA; Gaydos A; Tenser RB J Med Virol; 1996 Oct; 50(2):198-203. PubMed ID: 8915888 [TBL] [Abstract][Full Text] [Related]
31. Quantitative structure-activity relationships of N2-phenylguanines as inhibitors of herpes simplex virus thymidine kinases. Gambino J; Focher F; Hildebrand C; Maga G; Noonan T; Spadari S; Wright G J Med Chem; 1992 Aug; 35(16):2979-83. PubMed ID: 1323680 [TBL] [Abstract][Full Text] [Related]
33. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951 [TBL] [Abstract][Full Text] [Related]
34. Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. Griffiths A; Link MA; Furness CL; Coen DM J Virol; 2006 Jul; 80(13):6568-74. PubMed ID: 16775343 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effects on ganglionic herpes simplex virus infections by mutations or drugs that inhibit the viral polymerase and thymidine kinase. Jacobson J; Kramer M; Rozenberg F; Hu A; Coen DM Virology; 1995 Jan; 206(1):263-8. PubMed ID: 7831780 [TBL] [Abstract][Full Text] [Related]
36. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705 [TBL] [Abstract][Full Text] [Related]
37. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105 [TBL] [Abstract][Full Text] [Related]
39. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells. Balzarini J; Degrève B; Andrei G; Neyts J; Sandvold M; Myhren F; de Clercq E Gene Ther; 1998 Mar; 5(3):419-26. PubMed ID: 9614564 [TBL] [Abstract][Full Text] [Related]
40. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]